Mendell Helium Plc

Mendell Helium Plc

LLSE:MDH
3.15
GBX
0.00
(0.00%)
2024 Y
2025 Y
Revenue per Share
- -
- -
Basic EPS, GAAP
- -
- -
Free Cash Flow per Basic Share
- -
- -
Dividend per Share
- -
- -
Book Value per Share
0.01
- -
Tangible Book Value per Share
0.01
- -
Basic Weighted Avg Shares
341
341
Sales/Revenue/Turnover
- -
- -
Operating Margin (%)
-20,856.87
-237.3
Depreciation Expense
- -
- -
Net Income, GAAP
-1
-2
Effective Tax Rate (%)
- -
- -
Profit Margin (%)
-20,877.83
-408.08
Working Capital
- -
-1
LT Debt
- -
- -
Total Equity
2
1
Return on Invested Capital (%)
- -
- -
Return on Capital (%)
- -
- -
Return on Common Equity (%)
- -
-100.85

Capital Structure

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

USD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-36.65%
Free Cash Flow
- -
- -
-10.41%
Net Income, GAAP
- -
- -
16.64%
Sales/Revenue/Turnover
- -
- -
5,867.43%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Nicholas George Selby Tulloch
Sector
Health technology
Industry
Pharmaceuticals: other
Address
Perth United Kingdom
Business
Mendell Helium Plc is a United Kingdom-based natural resources and industrial gas development company focused on the acquisition, exploration, appraisal, and commercial production of high-grade helium and associated natural gas reserves in North America. The company operates within the upstream resource sector, targeting the critical gases market to supply high-purity helium for advanced technological, medical, and industrial end-users. Its core products, services, and operational capabilities comprise the geological evaluation, reservoir appraisal, and seismic surveying of helium-bearing formations; drilling, completion, and workover of extraction wells; extraction, separation, and wellhead processing of raw gas streams; production, purification, and wholesale supply of gaseous helium for use in magnetic resonance imaging (MRI) medical systems, semiconductor fabrication, aerospace pressurization and rocketry, fiber optic manufacturing, leak detection, and cryogenic scientific research; co-production, gathering, and commercial distribution of associated natural gas and natural gas liquids; and the construction, maintenance, and operation of localized gathering pipelines, compression facilities, and off-take delivery infrastructure. Headquartered in the United Kingdom and founded in 2020, the company concentrates its operational assets in the United States, specifically within the Hugoton Basin in Kansas. In recent major developments, the company completed a strategic transformation and business pivot from its legacy consumer health and CBD operations into a pure-play helium exploration and production entity, formally changing its name from Voyager Life Plc to Mendell Helium Plc. Complementing this repositioning, the company secured a strategic option agreement to acquire an interest in M3 Helium Corp, gaining immediate operational access to producing and drill-ready helium assets including the Rost, Nilson, and Smith wells in Kansas. In conjunction with this asset acquisition, Mendell Helium completed equity financing rounds to fund well recompletions, pipeline tie-ins, and production testing programs, phased out its legacy wellness operations, and restructured its executive leadership with specialized energy and natural resource exploration professionals.